Abstract
The incidence of gastro-oesophageal junction (GEJ) adenocarcinoma is increasing in Western countries and prognosis is poor since metastasis is most often present at diagnosis. We examined samples from 87 resected type II GEJ adenocarcinomas, 30 of these with endoscopic diagnostic biopsy material, to evaluate transforming growth factor alpha (TGF-α) expression and p53 overexpression by immunohistochemistry and in situ hybridization (for TGF-α), in relation to biological and clinical behaviour. TGF-α messenger RNA (mRNA) and protein were detectable in neoplastic cells in 56% and 64% cases respectively. TGF-α mRNA was detected in intra- and peritumoral lymphocytes and those of metastatic lymph nodes. TGF-α protein expression was significantly associated with tumour progression (P = 0.025) and lymph node metastasis (P< 0.05). The strong TGF-α expression found in neoplastic cells inside blood and lymphatic vessels and in metastatic localizations suggests that TGF-α-positive GEJ adenocarcinomas could have a more aggressive biological phenotype. The expression of TGF-α mRNA and protein in both inflammatory and neoplastic cells indicates that TGF-α is directly synthesized by both cell compartments. Finally, since TGF-α expression was associated with lymph node metastasis, its detection in preoperative perendoscopic biopsies might identify patients with more aggressive tumours who may need additional therapy, including neo-adjuvant treatment. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
American Joint Committee on Cancer (1997). Cancer Staging Manual, pp. 71–76, 5th edition. Lippincott-Raven: Philadelphia
Bajaj-Elliott M, Poulsom R, Pender SL, Wathen NC and Macdonald TT (1998) Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest 102: 1473–1480
Blot WJ, Devesa SS, Kneller RW and Fraumeni JF (1991) Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 265: 1287–1289
Bosh A, Frias Z and Caldwell WL (1979) Adenocarcinoma of the esophagus. Cancer 43: 1557–1560
Cai Y-C, Barnard G, Hiestand L, Woda B, Colby J and Banner B (1997) Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor α. Am J Surg Pathol 21: 1373–1377
Casson AG, Kerkvliet N and Omalley F (1995) Prognostic value of p53 protein in esophageal adenocarcinoma. J Surg Oncol 60: 5–11
Casson AG, Mukopadhay T, Cleary KR, Ro JY, Levin B and Roth JA (1991) p53 mutations in Barrett’s epithelium and esophageal cancer. Cancer Res 51: 4495–4499
Coggi G, Bosari S, Roncalli M, Graziani D, Bossi P, Viale R, Buffa R, Ferrero S, Piazza M, Blaudamura S, Segalin A, Bonavina L and Peraculia A (1997) p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathological correlations. Cancer 79: 425–432
De Jong KP, Stellema R, Karrenbeld A, Lousdtaal J, Gouw AS, Sluiter WJ, Peeters PMJ, Slooff MJH and Devries EGE (1998) Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53 and Ki67 in colorectal liver metastases and corresponding primary tumours. Hepatology 28: (4): 971–979
Derynk R (1988) Transforming growth factor α. Cell 54: 593–595
Filipe MI, Osborn M, Linehan J, Sanidas E, Brito MJ and Jankowski J (1995) Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer 71: 30–36
Foster JM, Willis J, Venkaeswarlu S, Lin Y, Ferguson K, Zboroskwa E, Brattan MG and Willson JKV (1999) Ectopic TGF-α expression in non-tumorigenic colon cancer cells results in in vivo progression by induction of angiogenesis and proliferation, and inhibition of apoptosis. Proceedings of the American Association for Cancer Research 40 (Abstract 1166),
Hartwell L (1992) Defects in a cell-cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 7: 543–546
Husemann B (1989) Cardia carcinoma considered as a distinct clinical entity. Br J Surg 76: 136–139
Iihara K, Shiozaki H, Tahara H, Kobayashi K, Inoue M, Tamura S, Miyata M, Oka H, Doki Y and Mori T (1993) Prognostic significance of transforming growth factor-α in human esophageal carcinoma. Cancer 71: 2902–2909
Imazeki F, Omata M, Nose H, Ohto M and Isono K (1992) p53 gene mutations in gastric and esophageal cancers. Gastroenterology 103: 892–896
Jakl RJ, Miholic J, Koller R, Markis E and Wolner E (1995) Prognostic factors in adenocarcinoma of the cardia. Am J Surg 169: 316–319
Kajiyama Y, Tsurumaru M, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M and Akiyama H (1997) Prognostic factors in adenocarcinoma of the gastric cardia: pathologic stage analysis and multivariate regression analysis. J Clin Onc 15: 2015–2021
MacFarlane SD, Hill LD, Jolly PE, Kozarek RA and Anderson RP (1988) Improved results of surgical treatment for oesophageal and gastroesophageal carcinoma after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 95: 415–422
Malden LT, Novak U and Burgess AW (1989) Expression of transforming growth factor alpha messenger mRNA in the normal and neoplastic gastro-intestinal tract. Int J Cancer 43: 380–384
Martin HM, Filipe MI and Morris RW (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859–862
Moskaluk A, Heitmiller R, Zahurak M, Schwab D, Sidransky D and Hamilton SR (1996) p53 and p21waf1/cip1 gene products in Barrett’s esophagus and adenocarcinoma of the esophagus and the esophagogastric junction. Hum Pathol 27: 1211–1220
Naito Y, Saito K, Shiba K, Ohuchi A, Saigenji K, Nagura H and Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491–3494
Nasim MM, Thomas DM, Alison MR and Filipe MI (1992) Transforming growth factor α expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma–an immunohistochemical study. Histopathology 20: 339–343
Ohno S, Tomisaki S and Oiwa H (1995) Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 180: 577–582
Patel DD, Bhatavdekar JM, Chikhlikar PR, Patel YV, Shah NG, Ghosh N, Suthar TP and Balar DB (1997) Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma. An immunohistochemical approach. J Surg Oncol 65: 111–116
Paterson IM, Easton DF, Corbishely CM and Gazet JC (1987) Changing distribution of adenocarcinoma of the stomach. Br J Surg 74: 481–482
Pera M, Cameron AJ, Trastek VF, Carpenter HA and Zinmeister AR (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104: 510–513
Powell J and McConkey CC (1992) The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1: 265–269
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E and Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318–324
Sauter ED, Coia LR, Eisenberg BL and Hanks GE (1995) Transforming growth factor-α expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31: 567–569
Schreiber AB, Winkler ME and Derynk R (1986) Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250–1253
Sharpe DAC and Moghissi K (1996) Resectional surgery in carcinoma of the oesophagus and cardia: what influences long-term survival?. Eur J Cardio-thorac Surg 10: 359–364
Siewert JR and Stein HJ (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction – classification, pathology and extent of resection. Dis Esophagus 9: 173–182
Sons HU and Borchard F (1986) Cancer of the distal esophagus and cardia: incidence, tumorous infiltration, and metastatic spread. Ann Surg 203: 188–195
Stemmermann G, Heffelfinger SC, Noffsinger A, Hui YZ, Miller MA and Fenoglio-Preiser C (1994) The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumour suppressor genes, and growth factors. Hum Pathol 25: 968–981
Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W and Lerut T (1996) Tumours of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 111: 85–95
Wang HH, Antonioli DA and Goldman H (1986) Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol 17: 482–487
Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL and Yang CS (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 15: 514–519
Wang L-S, Wu C-W, Hsieh M-J, Fahn H-J, Huang M-H and Chien K-Y (1993) Lymph node metastasis in patients with adenocarcinoma of gastric cardia. Cancer 71: 1948–1953
Webb JN and Busuttil A (1978) Adenocarcinoma of the oesophagus and of the oesophagogastric junction. Br J Surg 65: 475–480
Wolfe WG, Vaughan AI, Siegler HF, Hawthorne JW, Leopold KA and Duhay-Longsod FG (1988) Survival of patients with carcinoma of the oesophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 105: 749–756
Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA and Hamilton SR (1998) Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 153: 287–294
Yonemura Y, Takamura H, Ninomiya I, Fushida S, Tsugawa K, Kaji M, Nakai Y, Ohoyama S, Yawaguchi A and Miyazaki I (1992) Interrelationship between transforming growth factor-α and epidermal growth factor receptor in advanced gastric cancer. Oncology 49: 157–161
Younes M, Fernandez L and Lechago J (1996) Transforming growth factor alpha (TGF-α) expression in biopsies of colorectal carcinoma is a significant prognostic indicator. Anticancer Res 16: 1999–2004
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
D’Errico, A., Barozzi, C., Fiorentino, M. et al. Role and new perspectives of transforming growth factor-α (TGF- α) in adenocarcinoma of the gastro-oesophageal junction. Br J Cancer 82, 865–870 (2000). https://doi.org/10.1054/bjoc.1999.1013
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1013
Keywords
This article is cited by
-
The enlargement of the hormone immune deprivation concept to the blocking of TGFα-autocrine loop: EGFR signaling inhibition
Cancer Immunology, Immunotherapy (2006)